Taken together, these results suggest that the introduction of five point-mutations gave rise to the htM5 mutant that is likely to exert better effects for ameliorating NAFLD than the wild type. The gene discussed is TPM3; the disease is metabolic dysfunction-associated steatotic liver disease.